Posts Tagged ‘glp-1 agonists’
FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products
FDA has received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products.
[...]June 17, 2024: FL continues to spend money on Canadian drug importation that doesn’t import medicine; GLP-1 phishing scams increase
Florida still has not imported a single pill, patients seeking GLP-1 medicines at increased risk from phishing scams, the counterfeit medicine news from three other countries.
[...]June 10, 2024: U.S. drug shortages in 2023 and more counterfeit Ozempic seized
The FDA published its annual drug shortage report for 2023, CBP in Cincinnati seized multiple shipments of fake Ozempic, and international counterfeit medicine stories out of six different countries.
[...]Colorado’s Canadian Rx import plan fuels counterfeit Ozempic dangers
Executive Director Shabbir Safdar’s editorial ran on May 15, 2024 in Colorado Politics
[...]NABP RogueRx Activity Report examines illegal sales of injectable weight loss drugs
The NABP reports that illegal actors are selling desperate patients substandard and counterfeit versions of the new generation of weight loss medicine.
[...]